Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated Interstitial Lung DiseasE and Pulmonary Hypertension (PH): The CRuSADE PH Study

NCT03726398 is registered in ClinicalTrials.gov with Franz Rischard, DO as lead sponsor.

NCT NCT03726398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03726398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated Interstitial Lung DiseasE and Pulmonary Hypertension (PH): The CRuSADE PH Study
Lead sponsor
Franz Rischard, DO
Phase
Phase 2/3
Overall status
Withdrawn
Start date
September 1, 2018
Completion date
August 3, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, pulmonary hypertension, scleroderma